SCHEMBL12374908

SCHEMBL12374908

CC(C)(C)OC(=O)N1CCC(CC#Cc2nc(N)c3ncn(COC(C(=O)NC4CC4)C(O)CO)c3n2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.51
▸ ADORA1 P30542 2/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13657202 1.00 ADORA2A (0.51) ADORA2AADORA1ADORA3CCNA2CDK2
SCHEMBL13645791 0.94 ADORA2A (0.57) ADORA2AADORA1ADORA3
SCHEMBL13657170 0.93 ADORA2A (0.51) ADORA2AADORA1ADORA3CDK2
SCHEMBL12375002 0.92 ADORA2A (0.51) ADORA2AADORA1ADORA3
SCHEMBL13657205 0.91 ADORA2A (0.50) ADORA2AADORA1ADORA3
SCHEMBL12373543 0.91 ADORA2A (0.50) ADORA2AADORA1ADORA3
SCHEMBL14393606 0.90 ADORA2A (0.50) ADORA2AADORA1ADORA3BACE1
SCHEMBL14393655 0.89 ADORA2A (0.48) ADORA2AADORA1ADORA3
SCHEMBL13819543 0.89 ADORA2A (0.48) ADORA2AADORA1ADORA3
SCHEMBL14393326 0.88 ADORA2A (0.47) ADORA2AADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989431-B2 4-{3-[6-Amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester; for inflammation, such as organ, tissue or cell transplantation, angioplasty (PCTA), inflammation following ischemia/reperfusion, or grafting UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2011-08-02 — — US disclosed
Send feedback